tickdelta
tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

COOCooper Companies

Health care · Eye Care · Nasdaq

The Cooper Companies, Inc. (Cooper, we or the Company), is a leading global medical device company focused on helping people experience life's beautiful moments. 10-K, Item 1

COO quote by TradingView
Headquarters
San Ramon, CA
Next results
around Dec 3, 2026
Compare with peers → Embed
All key numbers (39, from the latest 10-K and 10-Q) From EDGAR
EPS (ttm)2.91Sales (ttm)4.2BNet income (ttm)570.3MSales growth+5.1%EPS growth-4.6%Sales Q/Q+0.6%
Free cash flow678.0MGross margin65.9%Oper. margin12.8%Net margin13.5%FCF margin16.0%ROE6.8%
ROA4.5%R&D / sales4.2%Dividend0.01Debt/Eq0.31Curr. ratio1.22Cash154.7M
Op. cash flow (ttm)1.0BEBITDA1.1BEBITDA margin25.9%Net debt2.4BQuick ratio0.77Interest cover6.83
ROIC4.2%Tax rate33.8%Stock pay / sales1.7%Shares out.190.2MShares Y/Y-0.2%Book / share43.80
Cash / share0.81Sales / share22.28Asset turnover0.33Inventory turns1.67Days sales out.74Sales 3Y CAGR+7.3%
Sales 5Y CAGR+11.0%EPS 3Y CAGR-1.2%EPS 5Y CAGR+9.2%

Hover or tap a number to see the XBRL line item and filing it comes from; click it to open that filing at SEC. What each number means. Looks wrong? Tell us.

Changes in the numbers

FY2025 against FY2024
  • Free cash flow rose 51%$288.1M → $433.7M · Cash from operations − capital expenditure · 10-K ↗
What management wrote about it → · Every company →

COO against Health care peers

Ten years, side by side → · All 60 →
GrowthProfitBalanceCleanInsiders
COOPeer median

Each side 0 to 100, ranked against every company we cover: relative position on reported figures, not a buy score. How

Every dot is one of the 60 companies, the better end on the right. Hover a dot for the company.

Sales growth
+5.1%40th of 60 · median +7.1%
Net margin
13.5%25th of 60 · median 9.6%
Return on equity
6.8%39th of 54 · median 13.1%
Free cash flow margin
16.0%27th of 56 · median 15.5%
Debt / equity (less is better)
0.3110th of 49 · median 0.66
COO and the 5 peers closest in revenue
CompanyRevenue (ttm)Sales growthGross marginNet marginROEFCF marginDebt / equity
COO Cooper Companies$4.2B +5.1%65.9%13.5%6.8%16.0%0.31
WAT Waters Corporation$4.6B +7.0%59.3%3.6%1.1%8.6%0.33
ILMN Illumina, Inc.$4.5B -0.7%67.9%19.7%28.5%23.3%0.57
MTD Mettler Toledo$4.2B +4.0%60.4%22.2%-20.7%-
ALGN Align Technology$4.2B +0.9%69.1%11.8%11.4%14.5%-
CRL Charles River Laboratories$4.0B -0.9%-1.0%1.2%10.0%0.76

From $3.3B of sales to $385.8M of profit

FY2022, from the 10-K income statement and revenue by region
United States to Revenue: $1.6BEurope to Revenue: $987.2MRest of World to Revenue: $682.7MRevenue to Gross profit: $2.1BRevenue to Cost of revenue: $1.2BGross profit to Operating profit: $507.6MGross profit to Operating expenses: $1.6BOperating profit to Net profit: $385.8MOperating profit to Tax & other: $121.8MOperating expenses to R&D: $110.3MOperating expenses to Sales, admin & other: $1.5B United States: $1.6B · 50% United States$1.6B50% Europe: $987.2M · 30% Europe$987.2M30% Rest of World: $682.7M · 21% Rest of World$682.7M21% Revenue: $3.3B Revenue$3.3B +13% Y/Y Gross profit: $2.1B · 65% margin Gross profit$2.1B65% margin +9% Y/Y Cost of revenue: $1.2B · 35% of revenue Cost of revenue$1.2B35% of revenue Operating profit: $507.6M · 15% margin Operating profit$507.6M15% margin +0% Y/Y Operating expenses: $1.6B · 49% of revenue Operating expenses$1.6B49% of revenue Net profit: $385.8M · 12% margin Net profit$385.8M12% margin −87% Y/Y Tax & other: $121.8M · 4% of revenue Tax & other$121.8M4% of revenue R&D: $110.3M · 3% of revenue R&D$110.3M3% of revenue Sales, admin & other: $1.5B · 46% of revenue Sales, admin & other$1.5B46% of revenue

Swipe sideways for the whole flow →

From $3.6B of sales to $294.2M of profit

FY2023, from the 10-K income statement and revenue by region
United States to Revenue: $1.8BEurope to Revenue: $1.0BRest of World to Revenue: $739.8MRevenue to Gross profit: $2.4BRevenue to Cost of revenue: $1.2BGross profit to Operating profit: $533.1MGross profit to Operating expenses: $1.8BOperating profit to Net profit: $294.2MOperating profit to Tax & other: $238.9MOperating expenses to R&D: $137.4MOperating expenses to Sales, admin & other: $1.7B United States: $1.8B · 50% United States$1.8B50% Europe: $1.0B · 29% Europe$1.0B29% Rest of World: $739.8M · 21% Rest of World$739.8M21% Revenue: $3.6B Revenue$3.6B +9% Y/Y Gross profit: $2.4B · 66% margin Gross profit$2.4B66% margin +10% Y/Y Cost of revenue: $1.2B · 34% of revenue Cost of revenue$1.2B34% of revenue Operating profit: $533.1M · 15% margin Operating profit$533.1M15% margin +5% Y/Y Operating expenses: $1.8B · 51% of revenue Operating expenses$1.8B51% of revenue Net profit: $294.2M · 8% margin Net profit$294.2M8% margin −24% Y/Y Tax & other: $238.9M · 7% of revenue Tax & other$238.9M7% of revenue R&D: $137.4M · 4% of revenue R&D$137.4M4% of revenue Sales, admin & other: $1.7B · 47% of revenue Sales, admin & other$1.7B47% of revenue

Swipe sideways for the whole flow →

From $3.9B of sales to $392.3M of profit

FY2024, from the 10-K income statement and revenue by region
United States to Revenue: $2.0BEurope to Revenue: $1.2BRest of World to Revenue: $773.6MRevenue to Gross profit: $2.6BRevenue to Cost of revenue: $1.3BGross profit to Operating profit: $705.7MGross profit to Operating expenses: $1.9BOperating profit to Net profit: $392.3MOperating profit to Tax & other: $313.4MOperating expenses to R&D: $155.1MOperating expenses to Sales, admin & other: $1.7B United States: $2.0B · 50% United States$2.0B50% Europe: $1.2B · 30% Europe$1.2B30% Rest of World: $773.6M · 20% Rest of World$773.6M20% Revenue: $3.9B Revenue$3.9B +8% Y/Y Gross profit: $2.6B · 67% margin Gross profit$2.6B67% margin +10% Y/Y Cost of revenue: $1.3B · 33% of revenue Cost of revenue$1.3B33% of revenue Operating profit: $705.7M · 18% margin Operating profit$705.7M18% margin +32% Y/Y Operating expenses: $1.9B · 49% of revenue Operating expenses$1.9B49% of revenue Net profit: $392.3M · 10% margin Net profit$392.3M10% margin +33% Y/Y Tax & other: $313.4M · 8% of revenue Tax & other$313.4M8% of revenue R&D: $155.1M · 4% of revenue R&D$155.1M4% of revenue Sales, admin & other: $1.7B · 45% of revenue Sales, admin & other$1.7B45% of revenue

Swipe sideways for the whole flow →

From $4.1B of sales to $374.9M of profit

FY2025, from the 10-K income statement and revenue by region
United States to Revenue: $2.1BEurope to Revenue: $1.3BRest of World to Revenue: $785.2MRevenue to Gross profit: $2.7BRevenue to Cost of revenue: $1.4BGross profit to Operating profit: $682.9MGross profit to Operating expenses: $2.0BOperating profit to Net profit: $374.9MOperating profit to Tax & other: $308.0MOperating expenses to R&D: $172.2MOperating expenses to Sales, admin & other: $1.8B United States: $2.1B · 50% United States$2.1B50% Europe: $1.3B · 31% Europe$1.3B31% Rest of World: $785.2M · 19% Rest of World$785.2M19% Revenue: $4.1B Revenue$4.1B +5% Y/Y Gross profit: $2.7B · 66% margin Gross profit$2.7B66% margin +3% Y/Y Cost of revenue: $1.4B · 34% of revenue Cost of revenue$1.4B34% of revenue Operating profit: $682.9M · 17% margin Operating profit$682.9M17% margin −3% Y/Y Operating expenses: $2.0B · 49% of revenue Operating expenses$2.0B49% of revenue Net profit: $374.9M · 9% margin Net profit$374.9M9% margin −4% Y/Y Tax & other: $308.0M · 8% of revenue Tax & other$308.0M8% of revenue R&D: $172.2M · 4% of revenue R&D$172.2M4% of revenue Sales, admin & other: $1.8B · 45% of revenue Sales, admin & other$1.8B45% of revenue

Swipe sideways for the whole flow →

Where each $100 of sales went

FY2022
FY2023
FY2024
FY2025
  • Cost of revenue
  • R&D
  • Sales, admin & other
  • Tax & other
  • Net profit

Band widths are the money. Gross profit is revenue less cost of revenue; operating expenses are gross profit less operating profit; R&D is from the income statement and the rest of the operating expenses is everything else; tax includes interest and other items when they are small. Y/Y is the change from the fiscal year before. Revenue by part only for the years in the last two 10-Ks' segment tables. The full income statement →

Profitability

3 of 4
  • ✓
    Net margin above the peer median13.5% vs 9.6%
  • ✓
    Gross margin up over 5 years63.1% → 65.5%
  • !
    Return on equity below 15%6.8%
  • ✓
    A profit in every one of 10 years
Net margin, FY2016 to FY2025: 13.9% → 9.2%

Balance sheet

3 of 4
  • ✓
    Interest covered more than 5 timesOperating income is 6.8× interest expense
  • ✓
    Debt smaller than equityDebt / equity 0.31 on the latest balance sheet (peer median 0.66)
  • ✓
    Current assets cover current liabilitiesCurrent ratio 1.22
  • !
    Net debt over 3 years of free cash flow$2.4B net debt, 3.5 years
Debt / equity at each year end, FY2016 to FY2025: 0.57 → 0.30
What the debt is made of ↓

Cash and shareholders

2 of 3
  • ✓
    Free cash flow positive in every one of 10 years$433.7M last year
  • !
    Share count up over 5 years+0.8%
  • ✓
    Cash from operations above net income$796.1M vs $374.9M
Free cash flow, FY2016 to FY2025: 357.0M → 433.7M

Each tick is a fact with a fixed rule (on /methodology), not a score or advice. A check without the numbers it needs is left out.

What the debt is made of, and when it is due

balance sheet of Jul 31, 2026
Debt: $2.5B Debt$2.5B Long-term debt: $1.9B · 75% Long-term debt$1.9B · 75% Short-term borrowings: $627.5M · 25% Short-term borrowings$627.5M · 25%

The debt note's own lines, 2025-10-31

Fixed rate $0Floating $1.5B Not stated $200K

Line, as the company names itKindRateFixed or floatingAmount
Term loansBank loans–floating$1.5B
Other––not stated$200K

From the debt note in the 10-K's XBRL (0001628280-25-055615), as the company tags it: by issue, by year, by currency or by kind. Lines from two ways of cutting the same debt can overlap, so they are not added up. Fixed or floating is read from the line's own name only; "not stated" when it says neither.

Left: the debt lines on the balance sheet (XBRL). Right: the principal due each year, from the debt note's maturity schedule; it can differ a little from the balance sheet, which shows the debt net of discounts and fees. Leases are not counted. The full schedule →

Revenue and net income, FY2016 to FY2025

Revenue 4.1B Net income 374.9M
FY2016 revenue 2.0B · Revenues, 0000711404-18-000047 FY2016 net income 273.9M · NetIncomeLoss, 0000711404-18-000047 2.0B FY2016 FY2017 revenue 2.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000711404-19-000051 FY2017 net income 372.9M · NetIncomeLoss, 0000711404-19-000051 2.1B FY2017 FY2018 revenue 2.5B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000711404-20-000042 FY2018 net income 139.9M · NetIncomeLoss, 0000711404-20-000042 2.5B FY2018 FY2019 revenue 2.7B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000711404-21-000038 FY2019 net income 466.7M · NetIncomeLoss, 0000711404-21-000038 2.7B FY2019 FY2020 revenue 2.4B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000711404-22-000053 FY2020 net income 238.4M · NetIncomeLoss, 0000711404-22-000053 2.4B FY2020 FY2021 revenue 2.9B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000711404-23-000072 FY2021 net income 2.9B · NetIncomeLoss, 0000711404-23-000072 2.9B FY2021 FY2022 revenue 3.3B · RevenueFromContractWithCustomerExcludingAssessedTax, 0000711404-24-000074 FY2022 net income 385.8M · NetIncomeLoss, 0000711404-24-000074 3.3B FY2022 FY2023 revenue 3.6B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-25-055615 FY2023 net income 294.2M · NetIncomeLoss, 0001628280-25-055615 3.6B FY2023 FY2024 revenue 3.9B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-25-055615 FY2024 net income 392.3M · NetIncomeLoss, 0001628280-25-055615 3.9B FY2024 FY2025 revenue 4.1B · RevenueFromContractWithCustomerExcludingAssessedTax, 0001628280-25-055615 FY2025 net income 374.9M · NetIncomeLoss, 0001628280-25-055615 4.1B FY2025

From XBRL in each 10-K. Hover a bar for the line item and filing. Full financials →

COO's income statement, balance sheet and cash flow as reported to the SEC in XBRL, one column per fiscal year. Hover a number to see the line item and filing it comes from. Where a company changed how it tags a line, the first tag it reported for that period is used. A number looks wrong? Tell us.

Annual Quarterly
Revenue4.1B
FY2016: 2.0BFY2017: 2.1BFY2018: 2.5BFY2019: 2.7BFY2020: 2.4BFY2021: 2.9BFY2022: 3.3BFY2023: 3.6BFY2024: 3.9BFY2025: 4.1B FY2017FY2019FY2021FY2023FY2025
Net income374.9M
FY2016: 273.9MFY2017: 372.9MFY2018: 139.9MFY2019: 466.7MFY2020: 238.4MFY2021: 2.9BFY2022: 385.8MFY2023: 294.2MFY2024: 392.3MFY2025: 374.9M FY2017FY2019FY2021FY2023FY2025
Free cash flow433.7M
FY2016: 357.0MFY2017: 466.4MFY2018: 475.3MFY2019: 421.1MFY2020: 176.2MFY2021: 524.2MFY2022: 450.4MFY2023: 215.0MFY2024: 288.1MFY2025: 433.7M FY2017FY2019FY2021FY2023FY2025
EPS (diluted)1.87
FY2016: 1.40FY2017: 1.88FY2018: 0.70FY2019: 2.33FY2020: 1.20FY2021: 14.79FY2022: 1.94FY2023: 1.48FY2024: 1.96FY2025: 1.87 FY2017FY2019FY2021FY2023FY2025
Dividend per share0.01
FY2016: 0.01FY2017: 0.01FY2018: 0.01FY2019: 0.01FY2020: 0.01FY2021: 0.01FY2022: 0.01FY2023: 0.01FY2024: -FY2025: - FY2017FY2019FY2021FY2023FY2025
Diluted shares200.0M
FY2016: 196.0MFY2017: 198.4MFY2018: 198.8MFY2019: 200.0MFY2020: 198.4MFY2021: 199.2MFY2022: 198.8MFY2023: 199.3MFY2024: 200.4MFY2025: 200.0M FY2017FY2019FY2021FY2023FY2025

Revenue by business segment

year to Oct 31, 2025
RevenueSharevs year before
Cooper Vision 2.7B67.0% +5.2%
Coopervision 2.7B67.0% +5.2%
Cooper Surgical 1.3B33.0% +4.9%
Coopersurgical 1.3B33.0% +4.9%

10-K 0001628280-25-055615, segment and revenue notes (XBRL).

Revenue by region

year to Oct 31, 2025
RevenueSharevs year before
United States 2.1B50.2% +4.5%
Europe 1.3B30.6% +8.4%
Rest of World 785.2M19.2% +1.5%

10-K 0001628280-25-055615, segment and revenue notes (XBRL).

Income statement

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue2.0B2.1B2.5B2.7B2.4B2.9B3.3B3.6B3.9B4.1B
Cost of revenue793.7M773.2M900.5M896.6M896.1M966.7M1.2B1.2B1.3B1.4B
Gross profit1.2B1.4B1.6B1.8B1.5B2.0B2.1B2.4B2.6B2.7B
R&D65.4M69.2M84.8M86.7M93.3M92.7M110.3M137.4M155.1M172.2M
SG&A722.8M799.1M973.3M996.2M992.5M1.2B1.3B1.5B1.5B1.6B
Operating income324.1M429.1M403.1M546.7M311.8M505.8M507.6M533.1M705.7M682.9M
Interest expense26.2M33.4M82.7M68.0M36.8M23.1M57.3M105.3M114.3M100.0M
Pretax income295.6M394.0M331.9M477.4M266.5M491.5M475.3M412.9M582.3M566.5M
Income tax20.7M21.1M192.0M10.7M28.1M-2.5B89.5M118.7M190.0M191.6M
Net income273.9M372.9M139.9M466.7M238.4M2.9B385.8M294.2M392.3M374.9M
EPS (diluted)1.401.880.702.331.2014.791.941.481.961.87
Diluted shares196.0M198.4M198.8M200.0M198.4M199.2M198.8M199.3M200.4M200.0M
Depreciation & amortization198.3M188.4M275.1M280.8M149.9M309.3M346.1M367.7M375.1M377.4M
EBITDA522.4M617.5M678.2M827.5M461.7M815.1M853.7M900.8M1.1B1.1B
Gross margin59.6%63.9%64.4%66.2%63.1%66.9%64.7%65.6%66.6%65.5%
Operating margin16.5%20.1%15.9%20.6%12.8%17.3%15.3%14.8%18.1%16.7%
Net margin13.9%17.4%5.5%17.6%9.8%100.8%11.7%8.2%10.1%9.2%
Revenue growth-+8.8%+18.4%+4.8%-8.4%+20.2%+13.2%+8.6%+8.4%+5.1%
EPS growth-+34.5%-62.6%+232%-48.4%+1130%-86.9%-23.7%+32.4%-4.6%

Balance sheet

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash100.8M88.8M77.7M89.0M115.9M95.9M138.2M120.8M107.6M110.6M
Receivables291.4M316.6M374.7M435.3M435.4M515.3M557.8M609.7M717.0M829.0M
Inventory417.7M454.1M468.8M506.9M570.4M585.6M628.7M735.6M802.7M846.0M
Current assets937.1M953.2M1.1B1.2B1.3B1.5B1.5B1.7B2.0B2.1B
Property & equipment877.7M910.1M976.0M1.1B1.3B1.3B1.4B1.6B1.9B2.1B
Goodwill2.2B2.4B2.4B2.4B2.4B2.6B3.6B3.6B3.8B3.9B
Total assets4.5B4.9B6.1B6.3B6.7B9.6B11.5B11.7B12.3B12.4B
Accounts payable107.4M142.1M146.4M150.1M176.0M161.4M248.8M261.9M260.5M300.4M
Current liabilities543.2M396.1M536.5M1.1B1.0B732.1M1.3B969.0M1.0B1.1B
Total debt1.5B1.2B2.0B1.8B1.8B1.5B2.7B2.6B2.6B2.5B
Total liabilities1.8B1.7B2.8B2.6B2.9B2.7B4.3B4.1B4.2B4.2B
Shareholders' equity2.7B3.2B3.3B3.6B3.8B6.9B7.2B7.6B8.1B8.2B
Retained earnings2.0B2.4B2.6B3.0B3.3B6.2B6.6B6.9B7.3B7.6B

Cash flow

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow509.6M593.6M668.9M713.2M486.6M738.6M692.4M607.5M709.3M796.1M
Capital spending152.6M127.2M193.6M292.1M310.4M214.4M242.0M392.5M421.2M362.4M
Free cash flow357.0M466.4M475.3M421.1M176.2M524.2M450.4M215.0M288.1M433.7M
Stock-based pay (added back)29.9M37.2M43.2M35.1M37.6M43.8M54.2M62.1M75.1M70.5M
Dividends paid2.9M2.9M2.9M3.0M3.0M3.0M3.0M3.0M00
Buybacks055.0M0156.1M47.8M24.8M78.5M00290.1M
Debt raised1.6B1.4B2.7B1.1B3.2B1.4B1.5B2.1B3.5B3.1B
Debt repaid1.5B1.4B1.9B1.9B3.2B1.4B561.5M2.0B3.5B3.2B
Investing cash flow-418.7M-381.3M-1.5B-351.3M-364.5M-450.3M-1.8B-449.0M-764.6M-372.9M
Financing cash flow-1.4M-227.9M844.4M-351.4M-95.5M-311.4M1.2B-173.9M39.2M-425.9M
Dividend per share0.010.010.010.010.010.010.010.01--

Stock-based pay and leases

From EDGAR
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Stock-based pay (expense)29.9M37.2M43.2M35.1M37.6M43.8M54.2M62.1M75.1M70.5M
Stock-based pay / revenue1.5%1.7%1.7%1.3%1.5%1.5%1.6%1.7%1.9%1.7%
Operating lease cost----41.2M44.1M45.0M48.1M47.4M56.2M
Operating lease cash paid----40.6M37.4M45.3M47.5M48.0M49.9M
Right-of-use assets----260.2M257.0M230.1M241.5M260.7M270.9M
Operating lease liabilities----270.1M267.4M241.0M253.8M269.4M278.3M
Finance lease liabilities----2.4M-----

From SEC's XBRL company facts (data.sec.gov). EBITDA = operating income + depreciation and amortization; free cash flow = operating cash flow - capital spending; total debt = long-term debt (with its current part) + short-term borrowings. Stock-based pay and leases are shown as the company reports them; Tickdelta does not take them out of earnings or add leases to debt. Click a number to open the filing in SEC's Inline XBRL viewer, where you can click the same number to see how it is tagged. Values a company later revised show as revised; the Revised numbers tab lists the changes.

Work on COO in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/COO/export.csv") into a cell.